Global Peptic Ulcer Drugs Market 2014-2018

Global Peptic Ulcer Drugs Market 2014-2018 is a new market research publication announced by Reportstack. A peptic ulcer is an open lesion that develops on the mucosal lining of the stomach and small intestine because of the caustic effect of the gastric acids and enzymes in these organs. The symptoms of peptic ulcers are pain in the abdomen, nausea, vomiting, and bloated stomach. The major symptoms include bleeding from the ulcer, which can be life-threatening. It is detected by bloody and sticky stools, often black in color. Peptic ulcers are caused mainly by a Helicobacter pylori infection followed by the overuse of OTC NSAIDs such as Naproxen, Aspirin and Ibuprofen. Peptic ulcers can be of two types based on the site of the ulcer: gastric ulcer and duodenal ulcer.

The analysts forecast that the Global Peptic Ulcer Drugs market to grow at a CAGR of 2.9 percent over the period 2013-2018. This report covers the present scenario and the growth prospects of the Global Peptic Ulcer Drugs market for the period 2014–2018. To calculate the market size, the report considers the revenue generated from the sales of various drugs used in the treatment of peptic ulcers that are available in the market.

The report Global Peptic Ulcer Drugs Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Peptic Ulcer Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
• Americas
• EMEA
• APAC
Key Vendors
• AstraZeneca plc
• Eisai Co. Ltd.
• Daewoong Pharmaceutical Co. Ltd.
• Takeda Pharmaceutical Co. Ltd.
Other Prominent Vendors

• Daiichi Sankyo
• Dr. Reddy's Laboratories
• Eumedica
• Ferring Pharmaceuticals
• Horizon Pharma
• Johnson and Johnson
• Merck Sharp and Dohme
• Otsuka Holdings
• Pfizer
• PharmaKing
• Pozen
• Rottapharm Madaus
• Taiho Pharmaceutical
• Zeria Pharmaceutical
• Zuventus Healthcare
Market Driver
• Increased Incidence of H. pylori Infections.
• For a full, detailed list, view our report.
Market Challenge
• Adverse Effect of PPIs.
• For a full, detailed list, view our report.
Market Trend
• Use of Combination Drugs.
• For a full, detailed list, view our report.
Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?


Companies Mentioned

AstraZeneca plc, Eisai Co. Ltd., Daewoong Pharmaceutical Co. Ltd., Takeda Pharmaceutical Co. Ltd., Daiichi Sankyo, Dr. Reddy's Laboratories, Eumedica, Ferring Pharmaceuticals, Horizon Pharma, Johnson and Johnson, Merck Sharp and Dohme, Otsuka Holdings, Pfizer, PharmaKing, Pozen, Rottapharm Madaus, Taiho Pharmaceutical, Zeria Pharmaceutical and Zuventus Healthcare

To view the table of contents and know more details please visit Global Peptic Ulcer Drugs Market 2014-2018.